Market Overview:
The global glottic cancer treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of glottic cancer, increasing awareness about glottic cancer treatment options, and technological advancements in the field of glottic cancer treatment. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global glottic cancer treatment market can be segmented into surgical treatments, drug treatments, and radiation therapies. The surgical treatments segment is further sub-segmented into laser surgery, microsurgery, and traditional surgery. The drug treatments segment is further sub-segmented into chemotherapy drugs and targeted therapy drugs. Based on application, the global Glottis Cancer Treatment Market can be divided into four segments: hospitals; clinics; ambulatory surgical centers (ASCs); and others (including research institutes). Geographically speaking North America dominates this market followed by Europe due States owing increase incidences rates for Glotto carcinoma over there .
Product Definition:
The treatment of Glottic cancer is important because it can cause the voice box to swell, making it difficult to breathe. Treatment may include radiation therapy, surgery, or a combination of both.
Surgical Treatment:
Surgical treatment is a medical procedure done to remove part or all of the tumor. The surgical procedures can be classified into two types: open surgery and endoscopic surgery. Open surgeries are generally used for cancer that has spread to other parts of the body, whereas endoscopic surgeries are performed on an outpatient basis and hence they are also known as minimally invasive surgeries.
Drug Treatment:
Glottic cancer is a type of cancer that occurs in the glottis, or voice box, of the throat. The most common symptom associated with this form of cancer is hoarseness. Other symptoms include weight loss and persistent cough.
The major risk factors for glottic carcinoma include tobacco smoking.
Application Insights:
Based on application, the global glottic cancer treatment market is segmented into hospital, clinic, ambulatory surgical center and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a large patient base and availability of advanced healthcare facilities. In addition, an increase in prevalence rates of smoking among patients coupled with high incidence rates has led to a significant rise in demand for surgery at hospitals over the past few years.
The clinic segment is expected to grow at a lucrative rate during the forecast period due to increasing awareness about early diagnosis & treatment along with rising disposable income levels & population growth across various regions including Asia Pacific and Middle East & Africa which further boosts product demand globally. Furthermore, an increase in spending capacity among consumers along with growing investments by governments towards cancer care will boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to high healthcare expenditure, technological advancements, and local presence of major players. The U.S., which is at the forefront of this region, accounted for a revenue share of over 80% in North America during the same year owing to its advanced healthcare infrastructure and large population base suffering from glottic cancer.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare facilities & infrastructure coupled with growing awareness among people about available treatment methods for glottic cancer along with increasing disposable income levels in emerging countries such as China & India are some factors responsible for this growth (Glossary: Disposable Income- It is an economic measure that indicates how much money a person has left after paying his or her basic expenses like food clothing shelter etc.).
Growth Factors:
- Increasing incidence of glottic cancer
- Rising awareness about glottic cancer and its treatment options
- Growing demand for minimally invasive glottic cancer treatments
- Technological advancements in glottic cancer treatment procedures
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Glottic Cancer Treatment Market Research Report
By Type
Surgical Treatment, Drug Treatment,
By Application
Hospital, Clinic, Ambulatory Surgical Center, Others,
By Companies
Novartis, Eli Lilly, Cipla, Amgen, Biocon, Bristol-Myers Squibb, Merck, Pfizer, Celgene, Roche, Teva,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Glottic Cancer Treatment Market Report Segments:
The global Glottic Cancer Treatment market is segmented on the basis of:
Types
Surgical Treatment, Drug Treatment,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Ambulatory Surgical Center, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Eli Lilly
- Cipla
- Amgen
- Biocon
- Bristol-Myers Squibb
- Merck
- Pfizer
- Celgene
- Roche
- Teva
Highlights of The Glottic Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical Treatment
- Drug Treatment
- By Application:
- Hospital
- Clinic
- Ambulatory Surgical Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glottic Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glottic cancer is a type of cancer that affects the voice box or larynx. Treatment for glottic cancer may include surgery, radiation therapy, and chemotherapy.
Some of the major companies in the glottic cancer treatment market are Novartis, Eli Lilly, Cipla, Amgen, Biocon, Bristol-Myers Squibb, Merck, Pfizer, Celgene, Roche, Teva.
The glottic cancer treatment market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glottic Cancer Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glottic Cancer Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glottic Cancer Treatment Market - Supply Chain
4.5. Global Glottic Cancer Treatment Market Forecast
4.5.1. Glottic Cancer Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glottic Cancer Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glottic Cancer Treatment Market Absolute $ Opportunity
5. Global Glottic Cancer Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glottic Cancer Treatment Market Size and Volume Forecast by Type
5.3.1. Surgical Treatment
5.3.2. Drug Treatment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glottic Cancer Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glottic Cancer Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Ambulatory Surgical Center
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glottic Cancer Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glottic Cancer Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glottic Cancer Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glottic Cancer Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glottic Cancer Treatment Demand Share Forecast, 2019-2026
9. North America Glottic Cancer Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glottic Cancer Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glottic Cancer Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Ambulatory Surgical Center
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glottic Cancer Treatment Market Size and Volume Forecast by Type
9.7.1. Surgical Treatment
9.7.2. Drug Treatment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glottic Cancer Treatment Demand Share Forecast, 2019-2026
10. Latin America Glottic Cancer Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glottic Cancer Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glottic Cancer Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Ambulatory Surgical Center
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glottic Cancer Treatment Market Size and Volume Forecast by Type
10.7.1. Surgical Treatment
10.7.2. Drug Treatment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glottic Cancer Treatment Demand Share Forecast, 2019-2026
11. Europe Glottic Cancer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glottic Cancer Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glottic Cancer Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Ambulatory Surgical Center
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glottic Cancer Treatment Market Size and Volume Forecast by Type
11.7.1. Surgical Treatment
11.7.2. Drug Treatment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glottic Cancer Treatment Demand Share, 2019-2026
12. Asia Pacific Glottic Cancer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glottic Cancer Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glottic Cancer Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Ambulatory Surgical Center
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glottic Cancer Treatment Market Size and Volume Forecast by Type
12.7.1. Surgical Treatment
12.7.2. Drug Treatment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glottic Cancer Treatment Demand Share, 2019-2026
13. Middle East & Africa Glottic Cancer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glottic Cancer Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glottic Cancer Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Ambulatory Surgical Center
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glottic Cancer Treatment Market Size and Volume Forecast by Type
13.7.1. Surgical Treatment
13.7.2. Drug Treatment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glottic Cancer Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glottic Cancer Treatment Market: Market Share Analysis
14.2. Glottic Cancer Treatment Distributors and Customers
14.3. Glottic Cancer Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eli Lilly
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cipla
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Amgen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biocon
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bristol-Myers Squibb
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Celgene
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Roche
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Teva
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
